Cargando…
Healthcare Worker Study Cohort to Determine the Level and Durability of Cellular and Humoral Immune Responses after Two Doses of SARS-CoV-2 Vaccination
We prospectively studied immunological response against SARS-CoV-2 after vaccination among healthcare workers without (group A) and with previous infection (group B). The analyses were collected at T0 (before the BNT162b2), T1 (before the second dose), T2 and T6 (1 and 6 months after the second dose...
Autores principales: | Dentone, Chiara, Fenoglio, Daniela, Ponzano, Marta, Cerchiaro, Matteo, Altosole, Tiziana, Franciotta, Diego, Portunato, Federica, Mikulska, Malgorzata, Taramasso, Lucia, Magnasco, Laura, Uras, Chiara, Magne, Federica, Ferrera, Francesca, Scavone, Graziana, Signori, Alessio, Vena, Antonio, Visconti, Valeria, Filaci, Gilberto, Sette, Alessandro, Grifoni, Alba, Di Biagio, Antonio, Bassetti, Matteo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697204/ https://www.ncbi.nlm.nih.gov/pubmed/36366293 http://dx.doi.org/10.3390/vaccines10111784 |
Ejemplares similares
-
Case report: Sotrovimab, remdesivir and nirmatrelvir/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19
por: Baldi, Federico, et al.
Publicado: (2023) -
Higher Mortality and Intensive Care Unit Admissions in COVID-19 Patients with Liver Enzyme Elevations
por: Taramasso, Lucia, et al.
Publicado: (2020) -
Clinical presentation of secondary infectious complications in COVID-19 patients in intensive care unit treated with tocilizumab or standard of care
por: Taramasso, Lucia, et al.
Publicado: (2021) -
Early Clinical Experience with Molnupiravir for Mild to Moderate Breakthrough COVID-19 among Fully Vaccinated Patients at Risk for Disease Progression
por: Vena, Antonio, et al.
Publicado: (2022) -
Reply to: “Antiviral Activity and Safety of Darunavir/Cobicistat for Treatment of COVID-19”
por: Nicolini, Laura Ambra, et al.
Publicado: (2020)